IMPACT BIOMEDICAL INC. business relationships
Companies named in IMPACT BIOMEDICAL INC.’s 10-K filed 2026-03-11, and public companies whose annual reports name IMPACT BIOMEDICAL INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 26 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in IMPACT BIOMEDICAL INC.’s annual report 2
“addition to utilizing the Microsoft cloud ecosystem, we have engaged a third-party service provider to enhance our cybersecurity posture” SEC filing
“| License Agreement with ProPhase Labs, Inc. dated July 18, 2022 incorporated by reference to Exhibit 10.18 to the Company's Amendment to the Registration Statement on Form S-1 (No. 333- 275062 ) filed with the SEC on November 21, 2023. |” SEC filing
Companies whose annual reports name IMPACT BIOMEDICAL INC. 1
“Agreement - On March 19, 2022, Impact BioMedical entered into a License Agreement ("Equivir License") with” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.